thiazolyl blue has been researched along with bombesin(6-14), hca(6)-leu(13)-psi(ch2n)-tac(14)- in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abi-Chaker, A; Block, NL; Halmos, G; Jaszberenyi, M; Jayakumar, AR; Krishan, A; Perez, R; Rick, FG; Schally, AV; Shamaladevi, N; Szalontay, L; Szepeshazi, K; Vidaurre, I | 1 |
1 other study(ies) available for thiazolyl blue and bombesin(6-14), hca(6)-leu(13)-psi(ch2n)-tac(14)-
| Article | Year |
|---|---|
Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.
Topics: Analysis of Variance; Animals; Apoptosis; Blotting, Western; Bombesin; Cell Line; Cell Proliferation; Cell Size; Cyclooxygenase 2; Dose-Response Relationship, Drug; Gastrin-Releasing Peptide; Gene Expression Profiling; Humans; Male; NF-kappa B; Peptide Fragments; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Rats; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Testosterone; Tetrazolium Salts; Thiazoles | 2013 |